Health Care

Galaxy Note 7 recall shows challenges of stronger batteries

Samsung's recall of 2.5 million Galaxy Note 7 phones after several dozen caught fire and exploded may stem from a subtle manufacturing error, but it highlights the challenge electronics makers face in packing ever more battery power into ever thinner phones, while rushing for faster release dates.

Mylan CEO to Testify Before House Over EpiPen Pricing

Mylan NL Chief Executive Officer Heather Bresch will appear at a Sept. 21 congressional hearing over price increases for its allergy auto-injector EpiPen, the U.S. House of Representatives Oversight Committee said in a statement on Wednesday.

St. Jude Sues Short-Seller Over Heart Device Allegations

St. Jude Medical Inc on Wednesday filed a lawsuit against short-selling firm Muddy Waters and cyber security company MedSec Holdings Ltd, saying they intentionally disseminated false information about its heart devices to manipulate its stock.

NY attorney general probes EpiPen manufacturer

New York's attorney general says his office is investigating Mylan Pharmaceuticals, which has been criticized for steep price increases for its emergency allergy treatment EpiPen.